Gain Therapeutics, Inc. (GANX) Marketable Securities, Current USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gain Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2022 to 2024.
  • Gain Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $2.02 M, a 82.9% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.02 M -$9.81 M -82.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5 M -$7.83 M -61% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $7.96 M -$3.89 M -32.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $9.87 M -$66.3 K -0.67% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $11.8 M Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $12.8 M Dec 31, 2022 10-K 2024-03-26
Q3 2022 $11.9 M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $9.94 M Jun 30, 2022 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.